These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7075463)

  • 21. Experimental evidence for concentration-dependent plasma protein binding effects on the apparent half-lives of restrictively cleared drugs.
    Lima JJ
    J Pharm Sci; 1983 Apr; 72(4):461-2. PubMed ID: 6864491
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Does the elimination of medication interest the physician?].
    Singlas E
    Sem Hop; 1981 Oct 18-25; 57(39-40):1648-52. PubMed ID: 6119792
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of the concepts of "half-life" and "clearance" in practice and in pharmacokinetics].
    Raaflaub J
    Schweiz Med Wochenschr; 1981 Sep; 111(38):1406-11. PubMed ID: 7280641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection.
    Knowles JA; Ruelius HW
    Arzneimittelforschung; 1972 Apr; 22(4):687-92. PubMed ID: 5068248
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines.
    Patwardhan RV; Mitchell MC; Johnson RF; Schenker S
    Hepatology; 1983; 3(2):248-53. PubMed ID: 6131860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.
    Faed EM
    Drug Metab Rev; 1984; 15(5-6):1213-49. PubMed ID: 6396057
    [No Abstract]   [Full Text] [Related]  

  • 30. Disposition of three benzodiazepines after single oral administration in man.
    Wretlind M; Pilbrant A; Sundwall A; Vessman J
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):28-39. PubMed ID: 15399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 32. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in the pharmacokinetics of drug substances in kidney diseases].
    Kudrin AN; Davydova ON; Androsova SO
    Klin Med (Mosk); 1980 May; 58(5):13-6. PubMed ID: 6991802
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple dose kinetics and drug dosage in patients with kidney disease.
    Dettli L; Spring P; Ryter S
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():211-24. PubMed ID: 5316403
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal and neonatal drug metabolism in man.
    Rane A; Tomson G
    Eur J Clin Pharmacol; 1980 Jul; 18(1):9-15. PubMed ID: 7398754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam.
    Greenblatt DJ; Sethy VH
    Psychopharmacology (Berl); 1990; 102(3):373-8. PubMed ID: 1979181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.
    Ochs HR; Greenblatt DJ; Knüchel M
    Br J Clin Pharmacol; 1983 Dec; 16(6):743-6. PubMed ID: 6140941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug metabolite kinetics.
    Houston JB
    Pharmacol Ther; 1981; 15(3):521-52. PubMed ID: 7048351
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics in the elderly.
    Triggs EJ; Nation RL; Long A; Ashley JJ
    Eur J Clin Pharmacol; 1975; 8(1):55-62. PubMed ID: 1233203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.